Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0001193125-26-229656 |
|---|---|
| Form Type | 4 |
| Filing Date | May 19, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,000
Total Value
$31,200.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 15,000 | $2.08 | $31,200.00 | 247,588 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | May 18, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 12,653 | Direct | โ | View Details |